Dexcom (DXCM) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.61% |
| Dec 31, 2025 | 8.12% |
| Sep 30, 2025 | 14.37% |
| Jun 30, 2025 | 15.78% |
| Mar 31, 2025 | 22.50% |
| Dec 31, 2024 | 22.04% |
| Sep 30, 2024 | 23.79% |
| Jun 30, 2024 | 26.90% |
| Mar 31, 2024 | 26.85% |
| Dec 31, 2023 | 26.74% |
| Sep 30, 2023 | 42.71% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 43.81% |
| Dec 31, 2022 | 42.92% |
| Sep 30, 2022 | 42.19% |
| Jun 30, 2022 | 45.66% |
| Mar 31, 2022 | 61.02% |
| Dec 31, 2021 | 65.05% |
| Sep 30, 2021 | 67.53% |
| Jun 30, 2021 | 68.38% |
| Mar 31, 2021 | 71.10% |
| Dec 31, 2020 | 71.17% |
| Sep 30, 2020 | 71.72% |
| Jun 30, 2020 | 74.38% |
| Mar 31, 2020 | 66.85% |
| Dec 31, 2019 | 66.96% |
| Sep 30, 2019 | 68.82% |
| Jun 30, 2019 | 71.39% |
| Mar 31, 2019 | 73.68% |
| Dec 31, 2018 | 73.32% |
| Sep 30, 2018 | 58.87% |
| Jun 30, 2018 | 58.01% |
| Mar 31, 2018 | 55.45% |
| Dec 31, 2017 | 53.53% |
| Sep 30, 2017 | 52.32% |
| Jun 30, 2017 | 48.41% |
| Mar 31, 2017 | 31.69% |
| Dec 31, 2016 | 27.30% |
| Sep 30, 2016 | 22.95% |
| Jun 30, 2016 | 19.53% |
| Dec 31, 2015 | 30.49% |